154 related articles for article (PubMed ID: 11791663)
1. Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis.
Cuende E; Vesga JC; Pérez LB; Ardanaz MT; Guinea J
Clin Exp Rheumatol; 2001; 19(6):764-5. PubMed ID: 11791663
[No Abstract] [Full Text] [Related]
2. Beware of the unilateral red eye: don't miss blinding uveitis.
Durkin SR; Casey TM
Med J Aust; 2005 Mar; 182(6):296-7. PubMed ID: 15777147
[No Abstract] [Full Text] [Related]
3. [Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis].
Silva CA; Silva CH; Robazzi TC; Lotito AP; Mendroni Junior A; Jacob CM; Kiss MH
J Pediatr (Rio J); 2004; 80(6):517-22. PubMed ID: 15622430
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.
Ravelli A; De Benedetti F; Viola S; Martini A
J Pediatr; 1996 Feb; 128(2):275-8. PubMed ID: 8636829
[TBL] [Abstract][Full Text] [Related]
5. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease.
Cimaz R; Von Scheven A; Hofer M
Swiss Med Wkly; 2012; 142():w13582. PubMed ID: 22573189
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis.
Sawar H; Espinoza LR; Gedalia A
J Rheumatol; 2004 Mar; 31(3):623; author reply 623-4. PubMed ID: 14994420
[No Abstract] [Full Text] [Related]
7. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases.
Stéphan JL; Zeller J; Hubert P; Herbelin C; Dayer JM; Prieur AM
Clin Exp Rheumatol; 1993; 11(4):451-6. PubMed ID: 8403593
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with methotrexate of a child with atlantoaxial subluxation from enthesitis-related arthritis.
Kobayashi N; Yasui K; Nagumo H; Agenatsu K; Koike K
Clin Exp Rheumatol; 2006; 24(2):211-2. PubMed ID: 16762165
[No Abstract] [Full Text] [Related]
9. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis.
Grom AA; Passo M
J Pediatr; 1996 Nov; 129(5):630-2. PubMed ID: 8917224
[No Abstract] [Full Text] [Related]
10. Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia.
Jain V; Maheshwari A; Gulati S; Kabra M; Kalra V
Indian J Pediatr; 2005 Sep; 72(9):789-91. PubMed ID: 16186683
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
Juneja M; Jain R; Mishra D
Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
[TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis.
Pay S; Dinc A; Simsek I; Can C; Erdem H
Rheumatol Int; 2000 Dec; 20(1):25-7. PubMed ID: 11149657
[TBL] [Abstract][Full Text] [Related]
13. The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis.
Holzinger D; Frosch M; Kastrup A; Prince FH; Otten MH; Van Suijlekom-Smit LW; ten Cate R; Hoppenreijs EP; Hansmann S; Moncrieffe H; Ursu S; Wedderburn LR; Roth J; Foell D; Wittkowski H
Ann Rheum Dis; 2012 Jun; 71(6):974-80. PubMed ID: 22267331
[TBL] [Abstract][Full Text] [Related]
14. Juvenile idiopathic arthritis in the new world of biologics.
Ostring GT; Singh-Grewal D
J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
[TBL] [Abstract][Full Text] [Related]
15. Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis).
Agle LM; Rosenkranz M; Lehman TJ
Expert Opin Investig Drugs; 2003 Jan; 12(1):19-28. PubMed ID: 12517251
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis.
Weiss AH; Wallace CA; Sherry DD
J Pediatr; 1998 Aug; 133(2):266-8. PubMed ID: 9709718
[TBL] [Abstract][Full Text] [Related]
17. Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab.
Takezaki S; Okura Y; Ichikawa M; Suzuki D; Ohshima J; Kaneda M; Cho Y; Yamada M; Kawamura N; Iguchi A; Kobayashi I; Ariga T
Mod Rheumatol; 2012 Aug; 22(4):621-4. PubMed ID: 22072226
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate.
Fox EJ; Leeder JS; Ye SQ; Becker ML
J Rheumatol; 2013 May; 40(5):741-2. PubMed ID: 23637381
[No Abstract] [Full Text] [Related]
19. JAMA patient page. Juvenile idiopathic arthritis.
Chang HJ; Burke AE; Glass RM
JAMA; 2010 Apr; 303(13):1328. PubMed ID: 20371795
[No Abstract] [Full Text] [Related]
20. Macrophage activation syndrome.
Ravelli A
Curr Opin Rheumatol; 2002 Sep; 14(5):548-52. PubMed ID: 12192253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
